207 related articles for article (PubMed ID: 32559289)
1. Development and Application of a Transcriptomic Signature of Bioactivation in an Advanced In Vitro Liver Model to Reduce Drug-induced Liver Injury Risk Early in the Pharmaceutical Pipeline.
Kang W; Podtelezhnikov AA; Tanis KQ; Pacchione S; Su M; Bleicher KB; Wang Z; Laws GM; Griffiths TG; Kuhls MC; Chen Q; Knemeyer I; Marsh DJ; Mitra K; Lebron J; Sistare FD
Toxicol Sci; 2020 Sep; 177(1):121-139. PubMed ID: 32559289
[TBL] [Abstract][Full Text] [Related]
2. Application of a Rat Liver Drug Bioactivation Transcriptional Response Assay Early in Drug Development That Informs Chemically Reactive Metabolite Formation and Potential for Drug-induced Liver Injury.
Monroe JJ; Tanis KQ; Podtelezhnikov AA; Nguyen T; Machotka SV; Lynch D; Evers R; Palamanda J; Miller RR; Pippert T; Cabalu TD; Johnson TE; Aslamkhan AG; Kang W; Tamburino AM; Mitra K; Agrawal NGB; Sistare FD
Toxicol Sci; 2020 Sep; 177(1):281-299. PubMed ID: 32559301
[TBL] [Abstract][Full Text] [Related]
3. A testing strategy to predict risk for drug-induced liver injury in humans using high-content screen assays and the 'rule-of-two' model.
Chen M; Tung CW; Shi Q; Guo L; Shi L; Fang H; Borlak J; Tong W
Arch Toxicol; 2014 Jul; 88(7):1439-49. PubMed ID: 24958025
[TBL] [Abstract][Full Text] [Related]
4. Moving beyond Binary Predictions of Human Drug-Induced Liver Injury (DILI) toward Contrasting Relative Risk Potential.
Aleo MD; Shah F; Allen S; Barton HA; Costales C; Lazzaro S; Leung L; Nilson A; Obach RS; Rodrigues AD; Will Y
Chem Res Toxicol; 2020 Jan; 33(1):223-238. PubMed ID: 31532188
[TBL] [Abstract][Full Text] [Related]
5. Development of a Battery of
Rathman J; Yang C; Ribeiro JV; Mostrag A; Thakkar S; Tong W; Hobocienski B; Sacher O; Magdziarz T; Bienfait B
Chem Res Toxicol; 2021 Feb; 34(2):601-615. PubMed ID: 33356149
[TBL] [Abstract][Full Text] [Related]
6. An in vitro coculture system of human peripheral blood mononuclear cells with hepatocellular carcinoma-derived cells for predicting drug-induced liver injury.
Oda S; Uchida Y; Aleo MD; Koza-Taylor PH; Matsui Y; Hizue M; Marroquin LD; Whritenour J; Uchida E; Yokoi T
Arch Toxicol; 2021 Jan; 95(1):149-168. PubMed ID: 32816093
[TBL] [Abstract][Full Text] [Related]
7. The Promise of New Technologies to Reduce, Refine, or Replace Animal Use while Reducing Risks of Drug Induced Liver Injury in Pharmaceutical Development.
Sistare FD; Mattes WB; LeCluyse EL
ILAR J; 2016 Dec; 57(2):186-211. PubMed ID: 28053072
[TBL] [Abstract][Full Text] [Related]
8. The application of omics-based human liver platforms for investigating the mechanism of drug-induced hepatotoxicity in vitro.
Jiang J; Pieterman CD; Ertaylan G; Peeters RLM; de Kok TMCM
Arch Toxicol; 2019 Nov; 93(11):3067-3098. PubMed ID: 31586243
[TBL] [Abstract][Full Text] [Related]
9. A high content screening assay to predict human drug-induced liver injury during drug discovery.
Persson M; Løye AF; Mow T; Hornberg JJ
J Pharmacol Toxicol Methods; 2013; 68(3):302-13. PubMed ID: 23933113
[TBL] [Abstract][Full Text] [Related]
10. The Liver Toxicity Knowledge Base (LKTB) and drug-induced liver injury (DILI) classification for assessment of human liver injury.
Thakkar S; Chen M; Fang H; Liu Z; Roberts R; Tong W
Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):31-38. PubMed ID: 28931315
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Transcriptional Biomarkers of Xenobiotic Receptor Activation in Rat Liver for the Early Assessment of Drug Safety Liabilities.
Podtelezhnikov AA; Monroe JJ; Aslamkhan AG; Pearson K; Qin C; Tamburino AM; Loboda AP; Glaab WE; Sistare FD; Tanis KQ
Toxicol Sci; 2020 May; 175(1):98-112. PubMed ID: 32119089
[TBL] [Abstract][Full Text] [Related]
12. Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model.
Eun JW; Bae HJ; Shen Q; Park SJ; Kim HS; Shin WC; Yang HD; Jin CY; You JS; Kang HJ; Kim H; Ahn YM; Park WS; Lee JY; Nam SW
J Appl Toxicol; 2015 Feb; 35(2):152-64. PubMed ID: 25231249
[TBL] [Abstract][Full Text] [Related]
13. Is toxicogenomics a more reliable and sensitive biomarker than conventional indicators from rats to predict drug-induced liver injury in humans?
Zhang M; Chen M; Tong W
Chem Res Toxicol; 2012 Jan; 25(1):122-9. PubMed ID: 22122743
[TBL] [Abstract][Full Text] [Related]
14. Prediction of Drug-Induced Liver Injury in Micropatterned Co-cultures Containing iPSC-Derived Human Hepatocytes.
Ware BR; Berger DR; Khetani SR
Toxicol Sci; 2015 Jun; 145(2):252-62. PubMed ID: 25716675
[TBL] [Abstract][Full Text] [Related]
15. Minimizing DILI risk in drug discovery - A screening tool for drug candidates.
Schadt S; Simon S; Kustermann S; Boess F; McGinnis C; Brink A; Lieven R; Fowler S; Youdim K; Ullah M; Marschmann M; Zihlmann C; Siegrist YM; Cascais AC; Di Lenarda E; Durr E; Schaub N; Ang X; Starke V; Singer T; Alvarez-Sanchez R; Roth AB; Schuler F; Funk C
Toxicol In Vitro; 2015 Dec; 30(1 Pt B):429-37. PubMed ID: 26407524
[TBL] [Abstract][Full Text] [Related]
16. Use of micropatterned cocultures to detect compounds that cause drug-induced liver injury in humans.
Khetani SR; Kanchagar C; Ukairo O; Krzyzewski S; Moore A; Shi J; Aoyama S; Aleo M; Will Y
Toxicol Sci; 2013 Mar; 132(1):107-17. PubMed ID: 23152190
[TBL] [Abstract][Full Text] [Related]
17. Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury.
Laifenfeld D; Qiu L; Swiss R; Park J; Macoritto M; Will Y; Younis HS; Lawton M
Toxicol Sci; 2014 Jan; 137(1):234-48. PubMed ID: 24136188
[TBL] [Abstract][Full Text] [Related]
18. Metabolic activation and drug-induced liver injury: in vitro approaches for the safety risk assessment of new drugs.
Gómez-Lechón MJ; Tolosa L; Donato MT
J Appl Toxicol; 2016 Jun; 36(6):752-68. PubMed ID: 26691983
[TBL] [Abstract][Full Text] [Related]
19. Control compounds for preclinical drug-induced liver injury assessment: Consensus-driven systematic review by the ProEuroDILI network.
Segovia-Zafra A; Villanueva-Paz M; Serras AS; Matilla-Cabello G; Bodoque-García A; Di Zeo-Sánchez DE; Niu H; Álvarez-Álvarez I; Sanz-Villanueva L; Godec S; Milisav I; Bagnaninchi P; Andrade RJ; Lucena MI; Fernández-Checa JC; Cubero FJ; Miranda JP; Nelson LJ
J Hepatol; 2024 May; ():. PubMed ID: 38703829
[TBL] [Abstract][Full Text] [Related]
20. Predicting Drug-Induced Liver Injury with Bayesian Machine Learning.
Williams DP; Lazic SE; Foster AJ; Semenova E; Morgan P
Chem Res Toxicol; 2020 Jan; 33(1):239-248. PubMed ID: 31535850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
